{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:04:11Z","timestamp":1790258651570,"version":"4.1.0"},"reference-count":57,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"unspecified","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2026,8,1]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>SLE is a complex autoimmune disease that causes significant health issues. In this study, SLE-related healthcare episodes, in-hospital mortality and resource use in Spain from 2016 to 2022 were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective, nationwide, repeated cross-sectional study, International Classification of Diseases, 10th Revision, data from Spain\u2019s National Hospital Discharge Registry were used to identify healthcare episodes with SLE (or its subtypes) coded as the principal diagnosis. Temporal trends were analysed and group comparisons were made using \u03c7\u00b2, Fisher\u2019s exact test, Student\u2019s t test and Mantel-Haenszel trend test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 24\u2009151 SLE episodes were identified, with the majority occurring in women (86.9%) and individuals aged 15\u201365 years (88.2%). SLE episodes increased from 3002 (6.5\/100 000 population) in 2016 to 4226 (8.8\/100 000 population) in 2022 (p&lt;0.001). Lupus nephritis episodes rose from 525 (1.13\/100 000 population) to 956 (2.0\/100 000 population; p&lt;0.001). Relative to all other hospitalisation episodes, SLE episodes had longer hospital stays (8.7 vs 7.1\u2009days; p&lt;0.001) and intensive care unit (ICU) stays (8.4 vs 4.9\u2009days; p=0.031). In-hospital mortality was low and stable. In unadjusted comparisons, mortality was lower among SLE episodes than among other hospitalisation episodes (0.3% vs 1.2%; p&lt;0.001). A larger proportion of in-hospital deaths during SLE episodes than during all other hospitalisation episodes occurred in individuals aged 15\u201365 years (42.5% vs 15.1%; p&lt;0.001). Although more deaths occurred in women, mortality was higher among men in unadjusted comparisons (0.7% vs 0.3%; p&lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SLE-related healthcare episodes increased in Spain from 2016 to 2022, but in-hospital mortality remained stable. SLE episodes involved longer hospital and ICU stays than other episodes. These results reflect healthcare utilisation patterns, not disease severity or patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2026-002171","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:40:17Z","timestamp":1790257217000},"page":"e002171","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["National trends in hospitalisation, in-hospital mortality and resource use for SLE in Spain from 2016 to 2022"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8833-3268","authenticated-orcid":false,"given":"Luis","family":"Arribas-P\u00e9rez","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Complejo Asistencial de Zamora, Zamora, Spain"},{"name":"Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Josu\u00e9","family":"Cordero-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Complejo Asistencial de Zamora, Zamora, Spain"},{"name":"Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Puertas-Miranda","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain"},{"name":"Connective Tissue Diseases Unit, Department of Internal Medicine, Hospital Universitario de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2590-9734","authenticated-orcid":false,"given":"Erik Gabriel","family":"D\u00edaz-Avila","sequence":"additional","affiliation":[{"name":"Department of Medicine. Faculty of Medicine, Universidad de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Salcedo-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain"},{"name":"Connective Tissue Diseases Unit, Department of Internal Medicine, Hospital Universitario de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo Guillermo","family":"Ternavasio-de la Vega","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Complejo Asistencial de Zamora, Zamora, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-9115","authenticated-orcid":false,"given":"Jorge L","family":"Torres-Triana","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Complejo Asistencial de Zamora, Zamora, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Marcos","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain"},{"name":"Connective Tissue Diseases Unit, Department of Internal Medicine, Hospital Universitario de Salamanca, Salamanca, Spain"},{"name":"Department of Medicine. Faculty of Medicine, Universidad de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2345-2873","authenticated-orcid":false,"given":"Antonio-J","family":"Chamorro","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain"},{"name":"Connective Tissue Diseases Unit, Department of Internal Medicine, Hospital Universitario de Salamanca, Salamanca, Spain"},{"name":"Department of Medicine. Faculty of Medicine, Universidad de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"2026092406400908000_13.2.e002171.1","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2026092406400908000_13.2.e002171.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.10.007"},{"key":"2026092406400908000_13.2.e002171.3","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/4uc7e8"},{"key":"2026092406400908000_13.2.e002171.4","doi-asserted-by":"crossref","first-page":"102780","DOI":"10.1016\/j.autrev.2021.102780","article-title":"Neuropsychiatric involvement in systemic lupus erythematosus: A review","volume":"20","author":"Carri\u00f3n-Barber\u00e0","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2026092406400908000_13.2.e002171.5","doi-asserted-by":"crossref","DOI":"10.1002\/acr2.70057","article-title":"Trends in Systemic Lupus Erythematous Mortality in the United States, 1999-2022","volume":"7","author":"Patel","year":"2025","journal-title":"ACR Open Rheumatol"},{"key":"2026092406400908000_13.2.e002171.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206334"},{"key":"2026092406400908000_13.2.e002171.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00668-1"},{"key":"2026092406400908000_13.2.e002171.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.12.008"},{"key":"2026092406400908000_13.2.e002171.9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.38239","article-title":"The Incidence and Prevalence of Systemic Lupus Erythematosus, 2002\u20132004: The Georgia Lupus Registry","volume":"66","author":"Lim","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026092406400908000_13.2.e002171.10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.38238","article-title":"Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program","volume":"66","author":"Somers","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026092406400908000_13.2.e002171.11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.rdc.2014.04.001","article-title":"Impact of race and ethnicity in the course and outcome of systemic lupus erythematosus","volume":"40","author":"Gonz\u00e1lez","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"2026092406400908000_13.2.e002171.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2643-6"},{"key":"2026092406400908000_13.2.e002171.13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5935\/0004-2749.20210076","article-title":"Lupus retinopathy: epidemiology and risk factors","volume":"84","author":"Azevedo","year":"2021","journal-title":"Arq Bras Oftalmol"},{"key":"2026092406400908000_13.2.e002171.14","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu381xx"},{"key":"2026092406400908000_13.2.e002171.15","first-page":"103","article-title":"Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study","volume":"1","author":"Segasothy","year":"1991","journal-title":"Lupus"},{"key":"2026092406400908000_13.2.e002171.16","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10245749","article-title":"Trends in Hospital Admissions and Death Causes in Patients with Systemic Lupus Erythematosus: Spanish National Registry","volume":"10","author":"Moreno-Torres","year":"2021","journal-title":"J Clin Med"},{"key":"2026092406400908000_13.2.e002171.17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/acr.22173","article-title":"Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies","volume":"66","author":"Yurkovich","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026092406400908000_13.2.e002171.18","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001329","article-title":"Validating claims-based algorithms for a systemic lupus erythematosus diagnosis in Medicare data for informed use of the Lupus Index: a tool for geospatial research","volume":"11","author":"Feldman","year":"2024","journal-title":"Lupus Sci Med"},{"key":"2026092406400908000_13.2.e002171.19","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000711","article-title":"Impact of severe infections in SLE: an observational study from the Spanish national registry","volume":"9","author":"Moreno-Torres","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2026092406400908000_13.2.e002171.20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez668"},{"key":"2026092406400908000_13.2.e002171.21","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1177\/0961203320952864","article-title":"Trends in mortality from lupus in Spain from 1980 to 2018","volume":"29","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2020","journal-title":"Lupus"},{"key":"2026092406400908000_13.2.e002171.22","unstructured":"Hospital discharge records in the national health system. Ministerio de Sanidad; 2024. Available: https:\/\/www.sanidad.gob.es\/estadEstudios\/estadisticas\/cmbd.htm [accessed 01 Nov 2024]"},{"key":"2026092406400908000_13.2.e002171.23","unstructured":"Poblaci\u00f3n residente por fecha, sexo y edad. Instituto Nacional de Estad\u00edstica (INE); 2024. Available: https:\/\/www.ine.es\/ [accessed 01 Nov 2024]"},{"key":"2026092406400908000_13.2.e002171.24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10729-006-9089-x","article-title":"Cost accounting and public reimbursement schemes in Spanish hospitals","volume":"9","author":"S\u00e1nchez-Mart\u00ednez","year":"2006","journal-title":"Health Care Manag Sci"},{"key":"2026092406400908000_13.2.e002171.25","unstructured":"Ministerio de Sanidad . Registro de actividad de atenci\u00f3n especializada\u2013RAE-CMBD. 2026. Available: https:\/\/www.sanidad.gob.es\/estadEstudios\/estadisticas\/cmbd.htm [Accessed 01 May 2026]."},{"key":"2026092406400908000_13.2.e002171.26","article-title":"Changes in the causes and predictors of lupus mortality in Spain through the last decades: data from the RELESSER registry","volume":"9","author":"Moriano","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2026092406400908000_13.2.e002171.27","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kead427","article-title":"Mortality and causes of death in systemic lupus erythematosus in New Zealand: a population-based study","volume":"63","author":"Lao","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026092406400908000_13.2.e002171.28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejr.2023.03.007","article-title":"Hospitalization and outcome of systemic lupus erythematosus patients admitted to the Rheumatology ward of Kasr Al-Ainy University Hospital","volume":"45","author":"Kotb","year":"2023","journal-title":"Egypt Rheumatol"},{"key":"2026092406400908000_13.2.e002171.29","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/acr.24356","article-title":"Mortality Among Hospitalized Individuals With Systemic Lupus Erythematosus in the US Between 2006 and 2016","volume":"73","author":"Anastasiou","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026092406400908000_13.2.e002171.30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5644\/ama2006-124.400","article-title":"Factors Predictive of In-Hospital Mortality in Patients with Systemic Lupus Erythematosus: A Single-Centre Retrospective Analysis","volume":"52","author":"Lertwises","year":"2023","journal-title":"Acta Med Acad"},{"key":"2026092406400908000_13.2.e002171.31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem233"},{"key":"2026092406400908000_13.2.e002171.32","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314543917"},{"key":"2026092406400908000_13.2.e002171.33","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315596597"},{"key":"2026092406400908000_13.2.e002171.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.08.018"},{"key":"2026092406400908000_13.2.e002171.35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/0961203320988607","article-title":"Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom","volume":"30","author":"Lorenzo-Vizcaya","year":"2021","journal-title":"Lupus"},{"key":"2026092406400908000_13.2.e002171.36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex412"},{"key":"2026092406400908000_13.2.e002171.37","doi-asserted-by":"crossref","first-page":"108845","DOI":"10.1016\/j.clim.2021.108845","article-title":"Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year","volume":"231","author":"Ramirez","year":"2021","journal-title":"Clin Immunol"},{"key":"2026092406400908000_13.2.e002171.38","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221093502"},{"key":"2026092406400908000_13.2.e002171.39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1573397116666200727145818","article-title":"Causes of Hospitalization in Systemic Lupus Erythematosus: A Narrative Review","volume":"17","author":"da Rosa","year":"2021","journal-title":"Curr Rheumatol Rev"},{"key":"2026092406400908000_13.2.e002171.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.034"},{"key":"2026092406400908000_13.2.e002171.41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10067-022-06476-6","article-title":"Systemic lupus erythematous readmissions have reduced: a 9-year longitudinal study of the nationwide readmission database","volume":"42","author":"Idolor","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2026092406400908000_13.2.e002171.42","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000539","article-title":"Hospitalisation for systemic lupus erythematosus associates with an increased risk of mortality in Australian patients from 1980 to 2014: a longitudinal, population-level, data linkage, cohort study","volume":"8","author":"Raymond","year":"2021","journal-title":"Lupus Sci Med"},{"key":"2026092406400908000_13.2.e002171.43","first-page":"892","article-title":"Factors associated with health services utilization in patients with systemic lupus erythematosus: a systematic review","volume":"28","author":"Ow","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2026092406400908000_13.2.e002171.44","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2013.778270"},{"key":"2026092406400908000_13.2.e002171.45","doi-asserted-by":"crossref","first-page":"808391","DOI":"10.1155\/2013\/808391","article-title":"Healthcare utilization and costs of systemic lupus erythematosus in Medicaid","volume":"2013","author":"Kan","year":"2013","journal-title":"Biomed Res Int"},{"key":"2026092406400908000_13.2.e002171.46","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.191187"},{"key":"2026092406400908000_13.2.e002171.47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2023.03.493","article-title":"EE192 The Relationship between Systematic Lupus Erythematosus Disease Activity Index (SLEDAI) and Healthcare Resource Utilization and Costs in Lupus Patients","volume":"26","author":"Levy","year":"2023","journal-title":"Value in Health"},{"key":"2026092406400908000_13.2.e002171.48","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/0961203320935176","article-title":"Clinical characterization, outcomes, and prognosis in patients with systemic lupus erythematosus admitted to the intensive care unit","volume":"29","author":"Arag\u00f3n","year":"2020","journal-title":"Lupus"},{"key":"2026092406400908000_13.2.e002171.49","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1177\/0961203320941941","article-title":"Systemic lupus erythematosus in the intensive care unit: a systematic review","volume":"29","author":"Su\u00e1rez-Avellaneda","year":"2020","journal-title":"Lupus"},{"key":"2026092406400908000_13.2.e002171.50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s42358-019-0073-9","article-title":"Clinical and epidemiologic characterization of patients with systemic lupus erythematosus admitted to an intensive care unit in Colombia","volume":"59","author":"Alvarez Barreneche","year":"2019","journal-title":"Adv Rheumatol"},{"key":"2026092406400908000_13.2.e002171.51","doi-asserted-by":"crossref","unstructured":"Avello A , Fernandez-Prado R , Abasheva D , et al . #1357 Regional and national hospitalization burden of lupus nephritis and systemic lupus erythematous in Spain. Nephrol Dial Transplant 2024;39. doi:10.1093\/ndt\/gfae069.410","DOI":"10.1093\/ndt\/gfae069.410"},{"key":"2026092406400908000_13.2.e002171.52","doi-asserted-by":"publisher","DOI":"10.1002\/art.37795"},{"key":"2026092406400908000_13.2.e002171.53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13023-024-03077-1","article-title":"Incidence and medical costs of lupus in Spanish hospitals: a retrospective database analysis","volume":"19","author":"Darba","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"2026092406400908000_13.2.e002171.54","first-page":"1770","article-title":"Hospitalization and mortality of patients with systemic lupus erythematosus","volume":"33","author":"Krishnan","year":"2006","journal-title":"J Rheumatol"},{"key":"2026092406400908000_13.2.e002171.55","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1177\/0961203316676641","article-title":"Hospitalization of patients with systemic lupus erythematosus is a major cause of direct and indirect healthcare costs","volume":"26","author":"Anandarajah","year":"2017","journal-title":"Lupus"},{"key":"2026092406400908000_13.2.e002171.56","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170072"},{"key":"2026092406400908000_13.2.e002171.57","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes391"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2026-002171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:40:24Z","timestamp":1790257224000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2026-002171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":57,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,9,24]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/lupus-2026-002171"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2026-002171","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}